1 INTRODUCTION  

  1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology

    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary

    3.1 Introduction
    3.2 Conclusion

4 Premium Insights

    4.1 Stem Cell Therapy Market Overview
    4.2 Regional Analysis: Market, By Type, 2018 vs 2024 (USD Million)
    4.3 Global Market, By Therapeutic Application, 2018–2024 (USD Million)
    4.4 Regional Analysis: Market, By Cell Source, 2018 vs 2024 (USD Million)

5 Market Overview

    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Growth Drivers
                    5.2.1.1 Growing Awareness Related to the Therapeutic Potency of Stem Cells in Effective Disease Management
                    5.2.1.2 Development of Advanced Genome-Based Cell Analysis Techniques
                    5.2.1.3 Increasing Public-Private Investments for the Development of Stem Cell Therapies
                    5.2.1.4 Development in Infrastructure Related to Stem Cell Banking and Processing
           5.2.2 Market Restraints
                    5.2.2.1 Unclear Regulatory Guidelines for Product Development & Commercialization
                    5.2.2.2 Socio-Ethical Issues Related to the Use of Escs in Disease Treatment
           5.2.3 Market Growth Opportunities
                    5.2.3.1 Supportive Regulations Across Developing Countries
                    5.2.3.2 Emergence of Ipscs as an Effective Alternative to Escs
           5.2.4 Market Challenges
                    5.2.4.1 Technical Limitations Related to Production Scale-Up
    5.3 Regulatory Landscape
           5.3.1 North America
           5.3.2 Europe
           5.3.3 Asia-Pacific
           5.3.4 Rest of the World

6 Industry Insights

    6.1 Introduction
    6.2 Supply Chain Analysis
           6.2.1 Key Stakeholders
           6.2.2 Key Influencers
    6.3 Pipeline Analysis
           6.3.1 Pipeline Analysis: Based on Phase of Clinical Study
           6.3.2 Pipeline Analysis: Based on Type
           6.3.3 Pipeline Analysis: Based on the Cell Line Used

7 Global Stem Cell Therapy Market, By Type

    7.1 Introduction
    7.2 Allogeneic Stem Cell Therapy Market, By Application
           7.2.1 Musculoskeletal Disorders
           7.2.2 Wounds and Injuries
           7.2.3 Surgeries
           7.2.4 Acute Graft-Versus-Host Disease (AGVHD)
           7.2.5 Other Applications
    7.3 Autologous Stem Cell Therapy Market, By Application
           7.3.1 Wounds and Injuries
           7.3.2 Cardiovascular Diseases
           7.3.3 Gastrointestinal Diseases
           7.3.4 Other Applications

8 Global Stem Cell Therapy Market, By Therapeutic Application

    8.1 Introduction
    8.2 Musculoskeletal Disorders
    8.3 Wounds and Injuries
    8.4 Cardiovascular Diseases
    8.5 Surgeries
    8.6 Gastrointestinal Diseases
    8.7 Other Applications

9 Global Stem Cell Therapy Market, By Cell Source

    9.1 Introduction
    9.2 Adipose Tissue-Derived Mesenchymal Stem Cells
    9.3 Bone Marrow-Derived Mesenchymal Stem Cells
    9.4 Cord Blood/Embryonic Stem Cells
    9.5 Other Cell Sources

10 Stem Cell Therapy Market, By Region

     10.1 Introduction
     10.2 North America
     10.3 Europe
     10.4 Asia-Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape

     11.1 Overview
     11.2 Market Ranking
     11.3 Strategic Benchmarking
             11.3.1 Product Development and Commercialization
     11.4 Competitive Scenario
     11.5 Recent Developments
             11.5.1 Product Launches and Approvals
             11.5.2 Expansions
             11.5.3 Agreements, Collaborations, and Partnerships

12 Company Profiles

     12.1 Introduction
             12.1.1 Geographic Benchmarking
     12.2 Osiris Therapeutics, Inc.
     12.3 Medipost Co., Ltd.
     12.4 Anterogen Co., Ltd.
     12.5 Pharmicell Co., Ltd.
     12.6 Holostem Terapie Avanzate Srl
     12.7 JCR Pharmaceuticals Co., Ltd.
     12.8 Nuvasive, Inc.
     12.9 RTI Surgical, Inc.
     12.10 Allosource